索引超出了数组界限。 文章摘要
|本期目录/Table of Contents|

[1]赵劲波 雷玉华 向家培 张长江 李元红.血清人中性粒细胞防御素1-3在冠状动脉粥样硬化性心脏病中的作用研究[J].国际心血管病杂志,2018,06:376-378.
点击复制

血清人中性粒细胞防御素1-3在冠状动脉粥样硬化性心脏病中的作用研究(PDF)

《国际心血管病杂志》[ISSN:1006-6977/CN:61-1281/TN]

期数:
2018年06期
页码:
376-378
栏目:
短篇论著
出版日期:
2019-02-01

文章信息/Info

Title:
-
作者:
赵劲波 雷玉华 向家培 张长江 李元红
Author(s):
-
关键词:
人中性粒细胞防御素1-3;  冠状动脉粥样硬化性心脏病;  生物标志物
Keywords:
-
分类号:
-
DOI:
10.3969/j.issn.1673-6583.2018.06.014
文献标识码:
-
摘要:
目的:探讨血清人中性粒细胞防御素1-3(human neutrophil peptide 1-3, HNP1-3)在冠状动脉粥样硬化性心脏病(冠心病)中的临床意义。方法:纳入108例冠心病患者设为病例组,其中重度冠心病患者32例,轻度冠心病患者76例,选取108例同期健康体检者作为对照组。收集两组一般资料,ELISA法检测血清HNP1-3水平,Spearman's 等级相关分析法分析血清HNP1-3水平与其他参数的相关性,受试者工作特征曲线(ROC曲线)分析HNP1-3诊断冠心病的检验效能,logist
Abstract:
-

参考文献/References


[1] Sanchis-Gomar F, Perez-Quilis C, Leischik R et al. Epidemiology of coronary heart disease and acute coronary syndrome [J]. Ann Transl Med, 2016, 4(13):256.
[2] Wirtz PH, Von Känel R. Psychological stress, inflammation, and coronary heart disease[J]. Curr Cardiol Rep, 2017, 19(11):111.
[3] Fava F, Lovegrove JA, Gitau R, et al. The gut microbiota and lipid metabolism: implications for human health and coronary heart disease[J]. Curr Med Chem, 2006, 13(25):3005-3021.
[4] Kougias P, Chai H, Lin PH, et al. Defensins and cathelicidins: neutrophil peptides with roles in inflammation, hyperlipidemia and atherosclerosis[J]. J Cell Mol Med, 2005, 9(1):3-10.
[5] Quinn K, Henriques M, Parker T, et al. Human neutrophil peptides: a novel potential mediator of inflammatory cardiovascular diseases[J]. Am J Physiol Heart Circ Physiol, 2008, 295(5):H1817-H1824.
[6] Yau MH, Wang Y, Lam KS, et al. A highly conserved motif within the NH2-terminal coiled-coil domain of angiopoietin-like protein 4 confers its inhibitory effects on lipoprotein lipase by disrupting the enzyme dimerization[J] J Biol Chem, 2009, 284(18):11942-11952.
[7] Bdeir K, Cane W, Canziani G, et al. Defensin promotes the binding of lipoprotein(a)to vascular matrix[J]. Blood, 1999, 94(6):2007-2019.
[8] López-Bermejo A, Chico-Julià B, Castro A, et al. Alpha defensins 1, 2, and 3: potential roles in dyslipidemia and vascular dysfunction in humans[J]. Arterioscler Thromb Vasc Biol, 2007, 27(5):1166-1171.
[9] Maneerat Y, Prasongsukarn K, Benjathummarak S, et al. Increased alpha-defensin expression is associated with risk of coronary heart disease: a feasible predictive inflammatory biomarker of coronary heart disease in hyperlipidemia patients[J]. Lipids Health Dis, 2016, 15:117.
[10] Maeda T, Sakiyama T, Kanmura S, et al. Low concentrations of human neutrophil peptide ameliorate experimental murine colitis[J]. Int J Mol Med, 2016, 38(6): 1777-1785.
[11] 许建民. 肺结核患者血浆中性粒细胞防御素1-3浓度与病情活动的关系[J]. 中国现代医生, 2011, 49(15):159-160.
[12] Alraies MC, Darmoch F, Tummala R, et al. Diagnosis and management challenges of in-stent restenosis in coronary arteries[J]. World J Cardiol, 2017, 9(8):640-651.
[13] Ragosta M. Left main coronary artery disease: importance, diagnosis, assessment, and management[J]. Curr Probl Cardiol, 2015, 40(3):93-126.

备注/Memo

备注/Memo:
作者单位:445000 恩施土家族苗族自治州中心医院内科心血管病中心
通信作者:李元红,Email:422107470@qq.com
更新日期/Last Update: 2018-11-30